Evidence map›Paper›PMID 41910366›Full record

ReviewJournal of medical virology2026

The Flavivirus NS3 Protein: Its Multifaceted Roles and Therapeutic Potential.

Haejeong Lee, Hee Cho, Michaela U Gack

Abstract readReview
In one paragraph

Review in Journal of medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haejeong LeeFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.ORCID https://orcid.org/0000-0003-2087-5077
Hee ChoFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.
Michaela U GackFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.

Funding

Defining the viral PTMome: Towards the development of novel antiviral approachesDP1AI169444 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI GACK, MICHAELA ULRIKE · 2021 to 2025
$5.6M
Regulation of Host Innate Immunity Against Viral InfectionR01AI087846 · NIAID · UNIVERSITY OF CHICAGO · PI GACK, MICHAELA ULRIKE · 2010 to 2020
$3.9M
Regulation of Host Innate Immunity Against Viral InfectionR37AI087846 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI Michaela Ulrike Gack · 2021 to 2026
$2.8M
Novel Role for Host Immunostimulatory RNA in Antiviral Immune DefenseR01AI165502 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI GACK, MICHAELA ULRIKE · 2021 to 2025
$2.3M
Host Regulation of Flavivirus InfectionR01AI186249 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI Michaela Ulrike Gack · 2025 to 2026
$1.1M
NIAID NIH HHS DP1 AI169444NIAID NIH HHS R01 AI087846NIAID NIH HHS R01 AI165502NIAID NIH HHS R01 AI186249NIAID NIH HHS R37 AI087846NIH HHS AI087846NIH HHS AI165502NIH HHS AI169444NIH HHS AI186249
6 · The paper itself

Abstract

Mosquito-borne flaviviruses are important human pathogenic viruses and can cause an array of symptoms ranging from asymptomatic to mild illness but can progress to severe disease conditions. Prominent members of the family Flaviviridae include Dengue virus, Zika virus, and West Nile virus, whose spread has increased globally due to the expansion of their respective mosquito vectors. Despite their importance as a public health concern, there are no FDA-approved antiviral drugs targeting these viruses in humans. One of the viral proteins essential for flavivirus replication is the NS3 protein, a highly conserved multifunctional enzyme implicated in viral polyprotein processing, viral RNA amplification, and modulation of several host cellular processes. In this review, we summarize NS3's functions in the flavivirus life cycle and its impact on clinical outcomes. We also discuss the regulation of NS3 activity through post-translational modifications and highlight ongoing research focused on developing NS3-targeted therapeutic approaches for flavivirus infections.

Indexed as

FlavivirusFlavivirus InfectionsRNA HelicasesSerine EndopeptidasesViral Nonstructural ProteinsAnimalsAntiviral AgentsDEAD-box RNA HelicasesHumansNucleoside-TriphosphataseProtein Processing, Post-TranslationalViral ProteasesVirus ReplicationAntiviral AgentsDEAD-box RNA HelicasesNS3 protein, flavivirusNucleoside-TriphosphataseRNA HelicasesSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesDengueflavivirusesimmunityNS3West Nile virusZika

Identifiers

PMID41910366
PMCPMC13034726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.